[{"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-001", "question": "A 14-year-old boy with juvenile idiopathic arthritis presents with acute onset of fever, rash, and joint swelling after starting etanercept therapy. Laboratory findings include elevated ferritin, pancytopenia, and hypertriglyceridemia. What is the most appropriate next step in management?", "options": ["Discontinue etanercept and initiate high-dose corticosteroids", "Administer intravenous immunoglobulin", "Start rituximab infusion", "Perform bone marrow biopsy immediately", "Initiate broad-spectrum antibiotics"], "answer": "A", "answer_index": 0, "explanation": "This presentation is consistent with macrophage activation syndrome (MAS), a life-threatening complication in rheumatic diseases like juvenile idiopathic arthritis, often triggered by biologic agents such as etanercept. Discontinuing the offending agent and starting high-dose corticosteroids is the initial management to control the cytokine storm. Bone marrow biopsy may confirm hemophagocytosis but is not the immediate next step, and antibiotics are inappropriate without evidence of infection.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "The presentation describes features consistent with macrophage activation syndrome (MAS), a severe complication of juvenile idiopathic arthritis (JIA) that can be triggered by medications like etanercept.  \nKey findings: acute fever, rash, joint swelling, elevated ferritin, pancytopenia, and hypertriglyceridemia.  \n\nThe most appropriate immediate step is to discontinue the suspected trigger (etanercept) and start high-dose corticosteroids to suppress the hyperinflammatory state.  \n\nThe answer is A"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-002", "question": "A 65-year-old man with hypertrophic cardiomyopathy develops sudden syncope during exercise. Echocardiography shows left ventricular outflow tract obstruction with a gradient of 80 mmHg. Despite beta-blocker therapy, symptoms persist. What is the most definitive management option?", "options": ["Surgical septal myectomy", "Alcohol septal ablation", "Implantable cardioverter-defibrillator placement", "Dual-chamber pacing", "Verapamil initiation"], "answer": "A", "answer_index": 0, "explanation": "Surgical septal myectomy is the gold standard for symptomatic hypertrophic cardiomyopathy with severe outflow tract obstruction refractory to medical therapy, offering superior long-term outcomes in experienced centers. Alcohol septal ablation is an alternative but carries risks like heart block and is less effective in younger patients. ICD placement addresses arrhythmic risk but not the obstruction itself.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "The patient has hypertrophic cardiomyopathy with significant LVOT obstruction (gradient >50 mmHg) and persistent symptoms despite beta-blocker therapy.  \nIn such cases, when medical therapy fails, invasive septal reduction therapy is indicated.  \nSurgical septal myectomy is considered the gold standard and most definitive treatment for eligible surgical candidates, as it directly relieves the obstruction and has durable results.  \n\nThe answer is A"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-003", "question": "A term neonate develops respiratory distress and hypotension shortly after birth. Physical exam reveals hepatomegaly and poor perfusion. Echocardiogram shows dilated cardiomyopathy. Maternal history includes untreated systemic lupus erythematosus. What is the underlying mechanism?", "options": ["Transplacental passage of anti-Ro/SSA antibodies causing atrioventricular block", "Congenital viral infection leading to myocarditis", "Inborn error of metabolism affecting cardiac function", "Asphyxia-induced hypoxic cardiomyopathy", "Genetic mutation in sarcomeric proteins"], "answer": "A", "answer_index": 0, "explanation": "Neonatal lupus from maternal anti-Ro/SSA antibodies can cause complete heart block and cardiomyopathy, leading to heart failure in the newborn. This is distinct from viral myocarditis, which typically presents later and lacks the maternal autoimmune history. Metabolic or genetic causes are less likely without additional syndromic features.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "The scenario describes a neonate with dilated cardiomyopathy, hepatomegaly, and poor perfusion, born to a mother with untreated systemic lupus erythematosus (SLE). Maternal anti-Ro/SSA antibodies are known to cross the placenta and can cause neonatal lupus syndromes, most commonly congenital heart block. However, these antibodies can also cause myocarditis and dilated cardiomyopathy, which aligns with the presentation of respiratory distress, hypotension, hepatomegaly, and echocardiogram findings.  \n\nThe other options are less likely given the maternal history:  \n- **B** (congenital viral infection) is possible but not specifically linked to maternal SLE.  \n- **C** (inborn error of metabolism) could cause cardiomyopathy but lacks other metabolic clues and is not tied to SLE.  \n- **D** (asphyxia-induced) would not typically present with isolated dilated cardiomyopathy and hepatomegaly without other asphyxia signs.  \n- **E** (genetic sarcomeric mutation) is usually not linked to maternal autoimmune disease.  \n\nThe best answer is **A**, recognizing that anti-Ro/SSA antibodies can cause more than just heart block—they can also cause myocarditis/dilated cardiomyopathy in neonates.  \n\nThe answer is (A)"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-004", "question": "A 28-year-old woman at 32 weeks gestation presents with severe preeclampsia and acute dyspnea. Echocardiography reveals peripartum cardiomyopathy with ejection fraction of 30%. What is the most critical intervention to improve maternal outcomes?", "options": ["Immediate delivery via cesarean section", "Initiate bromocriptine to suppress prolactin", "Administer intravenous furosemide and vasodilators", "Start anticoagulation with low-molecular-weight heparin", "Perform urgent cardiac transplantation evaluation"], "answer": "B", "answer_index": 1, "explanation": "Bromocriptine inhibits prolactin, which is implicated in the pathogenesis of peripartum cardiomyopathy, and has shown benefit in improving left ventricular function when added to standard heart failure therapy. Immediate delivery may be necessary for preeclampsia but does not directly address cardiomyopathy. Diuretics and vasodilators manage symptoms but are not disease-modifying in this context.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "In peripartum cardiomyopathy with severe preeclampsia and acute dyspnea, the immediate threat is acute decompensated heart failure.  \nThe most critical intervention is to reduce preload and afterload to improve cardiac function and relieve pulmonary congestion, which is achieved with IV diuretics (like furosemide) and vasodilators (like nitroglycerin or hydralazine, considering pregnancy safety).  \nImmediate delivery (A) may be needed but is not the *first* critical intervention before stabilizing heart failure. Bromocriptine (B) is not standard immediate therapy. Anticoagulation (D) is important but not the most critical first step. Transplantation evaluation (E) is not urgent management.  \n\nThe answer is (C)"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-005", "question": "In the ICU, a 55-year-old patient with septic shock on vasopressors develops acute kidney injury and metabolic acidosis. Despite fluid resuscitation, oliguria persists. Continuous renal replacement therapy is initiated. What is the most appropriate modality to optimize hemodynamic stability?", "options": ["Continuous venovenous hemodiafiltration with citrate anticoagulation", "Intermittent hemodialysis with bicarbonate buffer", "Sustained low-efficiency dialysis", "Peritoneal dialysis", "Continuous venovenous hemofiltration alone"], "answer": "A", "answer_index": 0, "explanation": "Continuous venovenous hemodiafiltration (CVVHDF) provides both convective and diffusive clearance, making it ideal for septic shock with acidosis, and citrate anticoagulation minimizes clotting while providing regional effects. Intermittent hemodialysis can cause hemodynamic instability in critically ill patients. Peritoneal dialysis is less efficient for rapid toxin removal in this setting.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "In septic shock with hemodynamic instability, continuous renal replacement therapies (CRRT) are preferred over intermittent or sustained low-efficiency dialysis to avoid significant blood pressure fluctuations.  \nCitrate anticoagulation is often used in CRRT to reduce bleeding risks and clotting events, and continuous venovenous hemodiafiltration (CVVHDF) provides both diffusion and convection, offering good solute clearance while maintaining hemodynamic stability.  \n\nAmong the options:  \n- **A (CVVHDF with citrate anticoagulation)** offers hemodynamic stability, effective clearance, and regional anticoagulation.  \n- B and C are intermittent or hybrid therapies, which can cause more hemodynamic shifts.  \n- D (peritoneal dialysis) is less common in the ICU for unstable septic shock.  \n- E (CVVH alone) provides convection but no diffusion; CVVHDF is often preferred for better acid-base and solute control.  \n\nThe best choice for optimizing hemodynamic stability in this scenario is **A**.  \n\nThe answer is (A)"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-006", "question": "A 45-year-old woman with rheumatoid arthritis on methotrexate develops progressive dyspnea and dry cough. High-resolution CT shows subpleural reticular opacities and traction bronchiectasis. Pulmonary function tests reveal restrictive pattern. What is the most likely diagnosis?", "options": ["Methotrexate-induced interstitial lung disease", "Rheumatoid arthritis-associated usual interstitial pneumonia", "Hypersensitivity pneumonitis from environmental exposure", "Non-specific interstitial pneumonia", "Cryptogenic organizing pneumonia"], "answer": "B", "answer_index": 1, "explanation": "Rheumatoid arthritis can cause interstitial lung disease with a usual interstitial pneumonia pattern, which is more common than methotrexate toxicity in long-term users. Methotrexate-induced ILD typically presents acutely and improves upon discontinuation, unlike this progressive course. Hypersensitivity pneumonitis would show upper lobe predominance and different triggers.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "The patient has rheumatoid arthritis (RA) with a restrictive pattern on PFTs and HRCT showing subpleural reticular opacities with traction bronchiectasis — classic features of usual interstitial pneumonia (UIP) pattern.  \nRA-associated interstitial lung disease most commonly presents as UIP.  \nMethotrexate can cause pneumonitis, but the imaging pattern is more often NSIP or hypersensitivity-like, not typically subpleural reticulation with traction bronchiectasis as described.  \nGiven the HRCT description, rheumatoid arthritis-associated usual interstitial pneumonia is the most likely diagnosis.  \n\nThe answer is (B)"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-007", "question": "A 2-year-old child with hypoplastic left heart syndrome post-Norwood procedure presents with cyanosis and metabolic acidosis. Echocardiography shows right ventricular dysfunction and tricuspid regurgitation. What is the most appropriate pharmacologic intervention?", "options": ["Milrinone infusion for inotropic support", "Prostaglandin E1 to maintain ductal patency", "Sildenafil for pulmonary hypertension", "Digoxin for rate control", "Epinephrine bolus for hypotension"], "answer": "A", "answer_index": 0, "explanation": "Milrinone provides inotropic support and pulmonary vasodilation, crucial for right ventricular failure in single-ventricle physiology after Norwood. Prostaglandin E1 is used preoperatively but not post-Norwood. Sildenafil targets pulmonary hypertension but lacks the inotropic effect needed here.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "The child has hypoplastic left heart syndrome post-Norwood procedure, which typically includes a systemic-to-pulmonary artery shunt.  \nPresenting with cyanosis and metabolic acidosis, along with right ventricular dysfunction and tricuspid regurgitation, suggests low cardiac output and possible pulmonary overcirculation or ventricular failure.  \nMilrinone provides inotropic support and afterload reduction (lusitropy) without significantly increasing myocardial oxygen demand, which is beneficial for a failing systemic right ventricle.  \nProstaglandin E1 is not indicated post-Norwood (shunt is already in place). Sildenafil could worsen systemic hypotension in this acute setting. Digoxin is not first-line for acute decompensation. Epinephrine bolus is for arrest or severe shock but not the most appropriate initial pharmacologic intervention for ventricular dysfunction without severe hypotension.  \n\nThe answer is A"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-008", "question": "A 70-year-old man with atrial fibrillation on anticoagulation develops acute chest pain and hypotension. Coronary angiography shows no obstructive disease, but left ventriculography reveals apical ballooning. What is the underlying pathophysiology?", "options": ["Catecholamine surge leading to transient myocardial stunning", "Spontaneous coronary artery dissection", "Myocarditis from viral infection", "Embolic occlusion of distal coronaries", "Vasospasm induced by ergonovine"], "answer": "A", "answer_index": 0, "explanation": "Takotsubo cardiomyopathy involves catecholamine-mediated myocardial stunning, mimicking acute coronary syndrome without angiographic abnormalities. Dissection would show vessel irregularities on angiography. Myocarditis typically presents with inflammatory markers and different ventricular patterns.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "The patient has apical ballooning on ventriculography, which is characteristic of Takotsubo (stress) cardiomyopathy.  \nThis condition is typically triggered by acute emotional or physical stress, leading to a surge in catecholamines that causes transient myocardial stunning without obstructive coronary disease.  \n\nThe answer is A"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-009", "question": "A 35-year-old pregnant woman at 28 weeks with antiphospholipid syndrome develops thrombocytopenia and elevated liver enzymes. Fetal monitoring shows growth restriction. What is the most appropriate management strategy?", "options": ["Low-dose aspirin and low-molecular-weight heparin continuation with close monitoring", "Immediate delivery to prevent maternal deterioration", "Plasmapheresis for antibody removal", "Intravenous immunoglobulin infusion", "Switch to unfractionated heparin"], "answer": "A", "answer_index": 0, "explanation": "In antiphospholipid syndrome during pregnancy, continuing low-dose aspirin and LMWH is standard to manage thrombotic risks and prevent complications like HELLP-like syndrome, with vigilant monitoring. Immediate delivery is premature at 28 weeks without severe features. IVIG is not first-line and reserved for refractory cases.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "This presentation in a pregnant woman with antiphospholipid syndrome (APS) at 28 weeks—thrombocytopenia, elevated liver enzymes, and fetal growth restriction—is highly suggestive of **catastrophic APS (CAPS)** or, in the obstetric context, possibly **severe preeclampsia/HELLP syndrome** complicating APS.  \n\nIn catastrophic APS, management involves **anticoagulation (usually heparin), high-dose corticosteroids, and often IVIG or plasmapheresis**. However, in pregnancy with APS and features of HELLP syndrome, the priority is often **delivery** if the mother is deteriorating, especially at 28 weeks when neonatal survival is reasonable with NICU care.  \n\nGiven the severity (thrombocytopenia, elevated liver enzymes, growth restriction), continuing pregnancy risks maternal multiorgan failure or fetal demise. Immediate delivery is typically indicated for severe preeclampsia/HELLP syndrome at this gestational age, and APS does not change that urgency; anticoagulation is maintained peri-delivery.  \n\nAmong the options:  \n- **A** (continue aspirin/LMWH with monitoring) is too conservative given severity.  \n- **B** (immediate delivery) addresses the life-threatening maternal condition and fetal compromise.  \n- **C** (plasmapheresis) might be used in CAPS but not as first step before delivery here.  \n- **D** (IVIG) can be adjunct but not first-line for this acute obstetric emergency.  \n- **E** (switch to UFH) is for peripartum management but doesn’t treat the core crisis.  \n\nThe most appropriate single best step is **immediate delivery** with coordinated peripartum anticoagulation and possibly steroids for fetal lung maturation if time allows, but the question emphasizes preventing maternal deterioration.  \n\nThe answer is B"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-010", "question": "In the critical care unit, a 60-year-old patient with acute respiratory distress syndrome on mechanical ventilation develops refractory hypoxemia despite prone positioning. Extracorporeal membrane oxygenation is considered. What is the primary indication for venovenous ECMO in this scenario?", "options": ["PaO2/FiO2 ratio less than 80 with FiO2 greater than 90%", "Hypercapnia unresponsive to increased minute ventilation", "Right ventricular failure on echocardiography", "Sepsis-induced myocardial depression", "Barotrauma from high plateau pressures"], "answer": "A", "answer_index": 0, "explanation": "Venovenous ECMO is indicated for severe ARDS when PaO2/FiO2 <80 on FiO2 >90%, despite optimal ventilatory support, to provide gas exchange. Hypercapnia alone may be managed with permissive strategies or ECCO2R. Right ventricular failure would prompt venoarterial ECMO consideration instead.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "The primary indication for venovenous ECMO in refractory hypoxemia in ARDS is severe hypoxemia despite maximal conventional management, which is typically defined by a very low PaO₂/FiO₂ ratio despite high FiO₂ and prone positioning.  \n\nAmong the options:  \n- **A** (PaO₂/FiO₂ < 80 with FiO₂ > 90%) aligns with common ECMO criteria for refractory hypoxemia (e.g., EOLIA trial criteria: PaO₂/FiO₂ < 50 for >3 hours or < 80 for >6 hours despite optimal care).  \n- **B** refers to hypercapnia, which is an indication for VV-ECMO when severe, but the question emphasizes refractory hypoxemia, not hypercapnia.  \n- **C** (right ventricular failure) would be an indication for VA-ECMO, not VV-ECMO.  \n- **D** (sepsis-induced myocardial depression) also suggests VA-ECMO.  \n- **E** (barotrauma) is a complication but not the primary indication for ECMO.  \n\nGiven the scenario of refractory hypoxemia despite prone positioning, the best answer is **A**.  \n\nThe answer is A"}]